Literature DB >> 23675886

Nanoelectrospray ionization mass spectrometric study of Mycobacterium tuberculosis CYP121-ligand interactions.

Katie M Duffell1, Sean A Hudson, Kirsty J McLean, Andrew W Munro, Chris Abell, Dijana Matak-Vinković.   

Abstract

Nondenaturing nanoelectrospray ionization mass spectrometry (nanoESI MS) of intact protein complexes was used to study CYP121, one of the 20 cytochrome P450s in Mycobacterium tuberculosis (Mtb) and an enzyme that is essential for bacterial viability. The results shed new light on both ligand-free and ligand-bound states of CYP121. Isolated unbound CYP121 is a predominantly dimeric protein, with a minor monomeric form present. High affinity azoles cause the dissociation of dimeric CYP121 into monomer, whereas weaker azole binders induce partial dimer dissociation or do not significantly destabilize the dimer. Complexes of CYP121 with azoles were poorly detected by nanoESI MS, indicating kinetically labile complexes that are easily prone to gas-phase dissociation. Unlike with the azoles, CYP121 forms a stable complex with its natural substrate cYY that does not undergo gas-phase dissociation. In addition, a series of potential ligands from fragment-based studies were used as a test for nanoESI MS work against CYP121. Most of these ligands formed stable complexes with CYP121, and their binding did not promote dimer dissociation. On the basis of binding to the monomer and/or CYP121 dimer it was possible to determine the relative order of their CYP121 binding affinities. The top nanoESI MS screening hit was confirmed by heme absorbance shift assay to have a Kd of 40 μM.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23675886     DOI: 10.1021/ac400236z

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  5 in total

1.  Cross-linking of dicyclotyrosine by the cytochrome P450 enzyme CYP121 from Mycobacterium tuberculosis proceeds through a catalytic shunt pathway.

Authors:  Kednerlin Dornevil; Ian Davis; Andrew J Fielding; James R Terrell; Li Ma; Aimin Liu
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

2.  Fragment-Based Approaches to the Development of Mycobacterium tuberculosis CYP121 Inhibitors.

Authors:  Madeline E Kavanagh; Anthony G Coyne; Kirsty J McLean; Guy G James; Colin W Levy; Leonardo B Marino; Luiz Pedro S de Carvalho; Daniel S H Chan; Sean A Hudson; Sachin Surade; David Leys; Andrew W Munro; Chris Abell
Journal:  J Med Chem       Date:  2016-03-22       Impact factor: 7.446

3.  A ligand-observed mass spectrometry approach integrated into the fragment based lead discovery pipeline.

Authors:  Xin Chen; Shanshan Qin; Shuai Chen; Jinlong Li; Lixin Li; Zhongling Wang; Quan Wang; Jianping Lin; Cheng Yang; Wenqing Shui
Journal:  Sci Rep       Date:  2015-02-10       Impact factor: 4.379

4.  Surface hydrophobics mediate functional dimerization of CYP121A1 of Mycobacterium tuberculosis.

Authors:  Amit Kumar; Christopher S Campomizzi; Natalie Jay; Shaun Ferguson; Emelie-Jo Scheffler; James Lioi; Chengjian Tu; Jun Qu; Claire Simons; D Fernando Estrada
Journal:  Sci Rep       Date:  2021-01-11       Impact factor: 4.379

5.  Structural Characterization and Ligand/Inhibitor Identification Provide Functional Insights into the Mycobacterium tuberculosis Cytochrome P450 CYP126A1.

Authors:  Jude T Chenge; Le Van Duyet; Shalini Swami; Kirsty J McLean; Madeline E Kavanagh; Anthony G Coyne; Stephen E J Rigby; Myles R Cheesman; Hazel M Girvan; Colin W Levy; Bernd Rupp; Jens P von Kries; Chris Abell; David Leys; Andrew W Munro
Journal:  J Biol Chem       Date:  2016-12-08       Impact factor: 5.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.